Stay updated on Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial

Sign up to get notified when there's something new on the Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The record now presents details of the Phase 1 study of epacadostat with sirolimus, including its design, eligibility criteria, treatment arms, and outcome measures.
    Difference
    53%
    Check dated 2026-11-09T13:54:37.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T15:47:07.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says the agency is transitioning to using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T16:38:50.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page continues to display a 403 Forbidden error. Its footer revision identifier was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T21:50:10.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T04:19:32.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Access to the study record now displays a 403 Forbidden error page, replacing the previous study content. The new screen shows a standard site footer and navigation but no trial details, indicating access is blocked.
    Difference
    19%
    Check dated 2026-09-21T22:38:05.000Z thumbnail image

Stay in the know with updates to Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial page.